PREOMICS
Updating the operating model
- Biotechnology
- January 2026
A4BEE prepared this analysis from publicly available sources. It reflects our own reading of PREOMICS's published strategy and is not endorsed by, or produced in cooperation with, PREOMICS. Company website
Strategic priorities
PREOMICS operates across 4 stated priorities, with the most concrete near-term plan anchored on high-throughput automation.
Scaling from manual iST workflows to true walk-away automation via APP96 platform with 96-sample parallel processing, reducing hands-on time to ~10 minutes and achieving median CV below 10% for reproducibility.
Establishing the Biognosys Group as unified proteomics-metabolomics-lipidomics powerhouse combining PreOmics sample prep, Biognosys CRO services/Spectronaut software, and biocrates metabolomics kits under Bruker affiliation.
Maintaining platform-agnostic iST technology compatible with all major mass spectrometers (Bruker timsTOF, Thermo, Sciex) to maximize addressable market while ensuring cross-continental method reproducibility.
-
01
High-Throughput Automation
Scaling from manual iST workflows to true walk-away automation via APP96 platform with 96-sample parallel processing, reducing hands-on time to ~10 minutes and achieving median CV below 10% for reproducibility.
-
02
Multiomics Ecosystem Integration
Establishing the Biognosys Group as unified proteomics-metabolomics-lipidomics powerhouse combining PreOmics sample prep, Biognosys CRO services/Spectronaut software, and biocrates metabolomics kits under Bruker affiliation.
-
03
Vendor-Neutral Standardization
Maintaining platform-agnostic iST technology compatible with all major mass spectrometers (Bruker timsTOF, Thermo, Sciex) to maximize addressable market while ensuring cross-continental method reproducibility.
-
04
Digital Lab Transformation
Transitioning from printed protocols to digital protocol cards, deploying OmicsFlow cloud orchestration for high-throughput DIA proteomics, and enabling integration with ARKSUITE for self-driving laboratory workflows.
Challenges we see
- Operations Manufacturing
High-Throughput Automation Scaling
PreOmics must scale from manual 16-sample PreON workflows to 96+ sample APP96 automation to meet drug discovery throughput demands where pharmaceutical customers process thousands of samples for cohort analysis and TPD screening.
Automation complexity increases the risk of methionine oxidation and requires precise flow control engineering to maintain data quality at scale.
- Digital Integration
LIMS/ELN Integration Gap
Sample preparation remains isolated from downstream Laboratory Information Management Systems (LIMS) and Electronic Lab Notebooks (ELN), creating manual data entry requirements and disconnected "data islands" that undermine traceability.
Without automated metadata capture from iST workflows to informatics platforms, audit trail gaps emerge and slow data-driven decision making.
- Compliance Regulatory
GMP/GxP Regulatory Compliance
As proteomics moves from research to clinical biomarker validation and drug development, PreOmics customers require GxP-compliant workflows with full data integrity per ALCOA+ principles and validated digital documentation.
ISO 9001:2015 certification covers manufacturing but clinical proteomics applications demand additional regulatory framework for 21 CFR Part 11 electronic records compliance.
- Digital Operations
Data Analysis Computational Bottleneck
Advances in sample preparation depth (up to 6,000 plasma proteins via P2-iST) create downstream computational bottlenecks where DIA data analysis requires massive parallelization in cloud environments.
OmicsFlow Linux-based orchestration tool is newly launched and requires enterprise IT integration expertise to deploy in AWS/Azure environments at scale.
- Operations Operations
Global Distribution Network Complexity
PreOmics relies on extensive distributor network spanning Asia-Pacific (China, Japan, India), Middle East, and Europe to deliver standardized iST kits globally while maintaining method reproducibility across continents.
A decentralized commercial model raises training consistency challenges and requires durable digital support infrastructure for remote troubleshooting.
Opportunities, by urgency and business impact
Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.
-
Manual Sample Preparation Variability
Legacy proteomics workflows require up to 48 hours and multiple manual interventions, introducing contamination risks, sample loss, and high coefficient of variation (CV >20%) that undermines longitudinal study data integrity.
Deploy A4BEE's process orchestration and closed-loop automation expertise to implement fully validated iST automation workflows with real-time quality monitoring and automated deviation detection.
-
Disconnected Proteomics Data Islands
Sample preparation data remains isolated from mass spectrometry results and downstream analysis platforms, requiring manual transcription and preventing real-time process intelligence during experiment execution.
Implement unified data platform connecting APP96/PreON instruments to LIMS/Spectronaut via OPC UA integration, enabling automatic metadata capture and "Golden Batch" comparison for quality trending.
-
Digital Protocol Documentation Gap
Transition from printed manuals to digital protocol cards creates need for validated electronic procedures that ensure users access current methodology versions while maintaining GxP compliance audit trails.
Deploy Laboratory Execution System (LES) framework with role-based access control, version-controlled digital SOPs, and automated compliance verification aligned with PreOmics' July 2025 digital protocol initiative.
-
AI-Enabled Drug Discovery Dataset Generation
Pharmaceutical TPD and chemoproteomics applications require massive-scale proteomic datasets for AI/ML model training, but current infrastructure lacks automated sample-to-insight pipelines that feed discovery algorithms.
Build end-to-end data lakehouse architecture with ontology-driven data models that transform raw proteomics output into AI-ready datasets for target identification and mode-of-action studies.
-
Self-Driving Lab Integration Complexity
Bruker's ARKSUITE acquisition creates pathway to "self-driving labs" but PreOmics sample preparation requires custom orchestration middleware to integrate with automated scheduling, robotic handling, and real-time process control systems.
Develop MTP-compliant process orchestration layer that positions PreOmics automation as plug-and-produce module within broader laboratory automation ecosystems, enabling smooth workflow sequencing.
What we'd propose
- Digital Lab
Proteomics Workflow Digitization Platform
End-to-end digital infrastructure connecting PreOmics sample preparation instruments to enterprise LIMS, data lakes, and analysis platforms via standardized protocols for complete experimental traceability.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital Lab
LIMS-Integrated Automation Control System
Unified control platform orchestrating APP96/PreON sample preparation with bidirectional LIMS communication for automated sample registration, method execution, and result reporting.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Enterprise AI
Real-Time Process Intelligence Dashboard
Advanced analytics platform providing live visibility into proteomics sample preparation performance with historical trending, Golden Batch comparison, and predictive quality indicators.
-
Ontology layer
DETAIL
-
Predictive models
DETAIL
-
Decision surfaces
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital Lab
GxP-Compliant Digital Protocol Framework
Validated Laboratory Execution System (LES) implementing PreOmics digital protocols with electronic signatures, training verification, and regulatory-compliant documentation for clinical proteomics applications.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Enterprise AI
AI-Ready Proteomics Data Lakehouse
Ontology-driven data platform transforming raw proteomics output into structured, AI-ready datasets for drug discovery applications including TPD screening, chemoproteomics, and biomarker identification.
-
Ontology layer
DETAIL
-
Predictive models
DETAIL
-
Decision surfaces
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
Digital maturity: today and target
Scored out of 100 across six dimensions. The target is what PREOMICS's own published ambition implies — not a perfect score.
- Automation Integration 65 → 90
- APP96 provides standalone automation but lacks enterprise orchestration layer connecting to LIMS/scheduling systems
- Data Connectivity 50 → 85
- Sample prep instruments operate as data islands; OmicsFlow addresses analysis but not prep-to-MS connectivity
- Process Intelligence 45 → 80
- Quality metrics tracked post-hoc; no real-time Golden Batch comparison or predictive quality scoring
- Regulatory Compliance 60 → 90
- ISO 9001 certified but clinical proteomics requires 21 CFR Part 11 electronic records infrastructure
- Cloud/AI Readiness 55 → 85
- OmicsFlow enables cloud analysis parallelization but lacks ontology-driven data lakehouse for AI/ML
- Global Standardization 70 → 90
- iST methodology ensures method consistency but digital training and remote support infrastructure needs expansion
Check this yourself
Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.
-
Self-assessment
Find Your LIMS
Answer a few questions about your lab and get a shortlist of LIMS that fit it.
-
Self-assessment
Data & AI Maturity
See how ready your data actually is for the AI work you're planning.
-
Market comparison
Digital Lab: Equipment & Integration Map
Which lab instruments connect to which systems, and where the gaps usually are.
-
Market comparison
Pharma Data Platform Use Cases — Ranked
Use cases ranked by how hard they are against what they're worth.
Think we've read this right?
Talk to usRelated reading
-
From Paper to Performance: Operational Efficiency and Compliance in Labs
Transform your QC lab with scalable digital solutions that embed compliance, boost efficiency, and deliver a future-ready competitive edge.
-
Developing a data and technology-driven flexible lab operations model
Now, when it becomes clear to the biotech companies that only by sharing the data they can thrive, everyone is looking for a solution.
-
Don’t let vendor lock-in hold your lab hostage.
How biotech labs avoid vendor lock-in by extending SCADA capabilities with flexible control platforms and multi-vendor integration.
-
Accelerating lab and manufacturing operations with MTP – a modular approach
Among the various modular and plug-n-produce approaches, the Modular Type Package (MTP) approach has emerged as a game-changer.
This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with PREOMICS, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].